Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$8K Buy
+600
New +$8.73K ﹤0.01% 9035
2014
Q2
Sell
-1,600
Closed -$25K 10562
2014
Q1
$25K Sell
1,600
-800
-33% -$12.8K ﹤0.01% 7793
2013
Q4
$40K Sell
2,400
-200
-8% -$2.93K ﹤0.01% 7251
2013
Q3
$33K Sell
2,600
-9,400
-78% -$111K ﹤0.01% 7406
2013
Q2
$138K Buy
+12,000
New +$135K ﹤0.01% 5502

Other funds holding GNTX

UBS's GNTX Position: Q3 2014 in Review

UBS reduced its Gentex (GNTX) stake by 16% in Q3 2014, selling an estimated $816K and leaving 300,398 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

UBS first reported a position in GNTX in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.18M in Q2 2014. 319 funds tracked by Wall St. Rank hold GNTX as of Q3 2014.

  • UBS held 300,398 shares of Gentex worth $4.02M as of Q3 2014.
  • UBS sold 56,142 Gentex shares in Q3 2014, an estimated $816K.
  • Gentex made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2239 holding.
  • UBS first reported a position in Gentex in Q2 2013 and has held it in 6 quarters since.
  • UBS's Gentex position peaked at $5.18M in Q2 2014.
  • 319 funds tracked by Wall St. Rank held Gentex as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.